Carcinosarcoma Clinical Trial
Official title:
A Multicenter, Open, Single Arm, Phase II Clinical Study of Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma
This study is to explore the treatment of advanced sarcomatoid carcinoma or Carcinosarcoma with Carrelizumab combined with Apatinib, in order to provide guidance and experience for new combined therapy in clinic.
A number of clinical studies have shown that PD-1 immunotherapy combined with anti-vascular target drugs has achieved good clinical efficacy in primary liver cancer, nasopharyngeal carcinoma, esophageal cancer and other tumors. For sarcomatoid carcinoma, which is a rare tumor with large heterogeneity, poor treatment effect and poor prognosis, clinicians are facing great confusion on how to find a good treatment regimen in clinic. The purpose of this study is to explore the treatment of advanced sarcomatoid carcinoma with PD-1 antibody Camrelizumab combined with anti-vascular target drug Apatinib. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04122872 -
GISAR German Interdisciplinary Sarcoma Registry
|
||
| Active, not recruiting |
NCT03570437 -
Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?
|
Phase 2 | |
| Completed |
NCT03395080 -
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma
|
Phase 2 | |
| Completed |
NCT00815945 -
Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
|
Phase 2 | |
| Withdrawn |
NCT03933761 -
Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy
|
Phase 2 | |
| Terminated |
NCT04688749 -
Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage
|
||
| Completed |
NCT03241745 -
A Study of Nivolumab in Selected Uterine Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT04458597 -
Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.
|
N/A | |
| Completed |
NCT04513665 -
ZW25 in Women With Endometrial Cancers
|
Phase 2 | |
| Recruiting |
NCT05252416 -
(VELA) Study of BLU-222 in Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Available |
NCT04681248 -
Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
|